Type 2 diabetes patients at higher risk of deadly liver disease

Many patients with potentially deadly liver cirrhosis and liver cancer are being diagnosed at late advanced stages of disease, according to a study led by Queen Mary University of London and the University of Glasgow. The study of 18 million people across Europe also suggests the people living with type 2 diabetes are at particular risk of this ‘silent disease’ and should be monitored closely to prevent life-threatening disease progression. Non-alcoholic fatty liver disease (NAFLD) affects up to a quarter of people in the West and is the most common cause of liver disease around the world. It is closely